Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: A systematic review with meta-analysis

Annals of Allergy, Asthma and Immunology

Volumn 89, Issue 5, 2002, Pages 479-484

  Yáñez, Anahí ^a   Rodrigo, Gustavo J ^b  

^a Hospital Aeronautico Central   (Argentina)

^b HOSPITAL CENTRAL DE LAS FUERZAS ARMADAS   (Uruguay)

Author keywords

[No Author keywords available]

Indexed keywords

AZELASTINE; BECLOMETASONE; BUDESONIDE; CORTICOSTEROID; FLUNISOLIDE; FLUTICASONE; HISTAMINE H1 RECEPTOR ANTAGONIST; LEVOCABASTINE;

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; EPISTAXIS; EYE DISEASE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; NOSE DISEASE; NOSE OBSTRUCTION; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; RHINORRHEA; SNEEZING; SYMPTOMATOLOGY; TASTE DISORDER; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0036878425     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62085-6     Document Type: Article

References (49)

1. International Consensus Report on the diagnosis and management of rhinitis. International Rhinitis Management Working Group. Allergy 1994;49(Suppl):1-34.
2. Van-Cauwenberge P, Bachert C, Passalaqua G, et al. Consensus statement on the treatment of allergy rhinitis. Allergy 2000;55:116-134.
3. Lundback B. Epidemiology of rhinitis an asthma. Clin Exp Allergy 1998;2:3-10.
4. Sly RM. Changing prevalence of allergy rhinitis and asthma. Ann Allergy Asthma Immunol 1999;82:233-248.
5. Holgate ST. The epidemic of allergy and asthma. Nature 1999;402(Suppl):B2-B4.
6. Sibbald B. Epidemiology of allergy rhinitis. In: Burr M, editor. Epidemiology of Clinical Allergy. Vol 31. Monographs in Allergy. Basel: Karger, 1993:61-69.
7. Wuthrich B, Schindler C, Leuenberger P, Ackermann-Liebrich U. Prevalence of atopy an pollinosis in the population of Switzerland (SAPALDIA study). Swiss Study on Air Pollution and Lung Disease in Adult. Int Arch Allergy Immunol 1995;106:149-156.
8. Strachan D, Sibbald B, Weiland S, et al. Worldwide variations in prevalence of symptoms of allergy rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol 1997;8:161-176.
9. Lemanske RF. A review of the current guidelines for allergic rhinitis and asthma. J Allergy Clin Immunol 1998;101:S392-S396.
10. 1 receptor antagonists in allergic rhinitis: systematic review or randomised controlled trials. BMJ 1997;317:1624-1629.
11. Clark S. Dangers of non-sedating antihistamines. Lancet 1997;349:1268.
12. 1-receptor-antagonist drugs. N Engl J Med 1994;330:1663-1670.
13. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
14. Glass CV. Meta-analysis in Social Research. Beverly Hills, CA: Sage, 1981.
15. Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res 1993;2:121-145.
16. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Orlando, FL: Academic Press, 1977.
17. Olkin I. Statistical and theoretical consideration in meta-analysis. Clin Epidemiol 1995;48:133-146.
18. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
19. Davies RJ, Lund VJ, Harten-Ash VJ. The effect of intranasal azelastine and beclomethasone on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis. Rhinology 1992;31:159-164.
20. Pelucchi A, Chiapparino A, Mastropasqua B, et al. Effect of intranasal azelastine and beclomethasone dipropionate on nasal symptoms, nasal cytology, and bronchial responsiveness to methacholine in allergic rhinitis in response to grass pollens. J Allergy Clin Immunol 1995;95:515-523.
21. Newson-Smith G, Powell M, Baehre M, et al. A placebo controlled study comparing the efficacy of intranasal azelastine and beclomethasone in the treatment of seasonal allergic rhinitis. Eur Arch Otorhinolaryngol 1997;254:236-241.
22. Wang D, Smitz J, De Waele M, Clement P. Effect of topical applications of budesonide and azelastine on nasal symptoms, eosinophil count and mediator release in atopic patients after nasal allergen challenge during the pollen season. Int Arch Allergy Immunol 1997;114:185-192.
23. Stern MA, Wade AG, Ridout SM, Cambell LM. Nasal budesonide offers superior symptom relief in perennial allergic rhinitis in comparison to nasal azelastine. Ann Allergy Asthma Immunol 1998;81:354-358.
24. Svensson C, Andersson M, Greiff L, et al. Effects of topical budesonide and levocabastine on nasal symptoms and plasma exudation responses in seasonal allergic rhinitis. Allergy 1998;53:367-374.
25. Di Lorenzo G, Gervasi F, Drago A, et al. Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitis. Clin Exp Allergy 1999;29:1367-1377.
26. Ortolani C, Foresi A, DiLorenzo G, et al. A double-blind, placebo-controlled comparison of treatment with fluticasone propionate and levocabastine in patients with seasonal allergic rhinitis. FLNCO2 Italian Study Group. Allergy 1999;54:1173-1180.
27. Berlin JM, Golden SJ, Teets S, et al. Efficacy of a steroid nasal spray compared with an antihistamine nasal spray in the treatment of perennial allergic rhinitis. J Am Osteopath Assoc 2000;100(Suppl):S8-S13.
28. van de Heyning PH, van Haesendonck J, Creten W, Rombaut N. Effect of topical levocabastine on allergic and non-allergic perennial rhinitis. A double-blind study, levocabastine vs. placebo, followed by an open, prospective, single-blind study on beclomethasone. Allergy 1988;43:386-391.
29. Munch EP, Soborg M, Norreslet TT, Mygind N. A comparative study of dexchlorpheniramine maleate sustained release tablets and budesonide nasal spray in seasonal allergic rhinitis. Allergy 1983;38:517-524.
30. Beswick KB, Kenyon GS, Cherry JR. A comparative study of beclomethasone dipropionate aqueous nasal spray with terfenadine tablets in seasonal allergic rhinitis. Curr Med Res Opin 1985;9:560-567.
31. Wood SE. Oral antihistamine or nasal steroid in hay fever: a double-blind double dummy comparative study of once daily oral astemizole vs. twice daily nasal beclomethasone dipropionate. Clin Allergy 1986;16:195-201.
32. Lancer JM, Jones AS, Stevens JC, et al. A comparison of rhinomanometry of beclomethasone and terfenadine in the treatment of seasonal rhinitis. J Laryngol Otol 1987;101:350-354.
33. Juniper EF, Kline PA, Hargreave FE, Dolovich J. Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol 1989;83:627-633.
34. Robinson AC, Cherry JR, Daly S. Double-bind cross-over trial comparing beclomethasone dipropionate and terfenadine in perennial rhinitis. Clin Exp Allergy 1989;19:569-573.
35. Bunnag G, Jarconharsri P, Wong EC. A double-blind comparison of nasal budesonide and oral astemizole for the treatment of perennial rhinitis. Allergy 1992;47:313-317.
36. Darnell R, Pecoud A, Richards DH. A double-blind comparison of fluticasone propionate aqueous nasal spray, terfenadine tablets and placebo in the treatment of patients with seasonal rhinitis to grass pollen. Clin Exp Allergy 1994;24:1144-1150.
37. Simpson RJ. Budesonide and terfenadine separately and in combination in the treatment of hay fever. Ann Allergy 1994;73:497-502.
38. van Bavel J, Findlay SR, Hampel FC Jr, et al. Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis. Arch Intern Med 1994;154:2699-2704.
39. Hilberg O. Effect of terfenadine and budesonide on nasal symptoms, olfaction, and nasal airway patency following allergen challenge. Allergy 1995;50:683-688.
40. Schoenwetter W, Lim J. Comparison of intranasal triamcinolone acetonide with oral loratadine for the treatment of patients with seasonal allergic rhinitis. Clin Ther 1995;17:479-492.
41. Bernstein DI, Creticos PS, Busse WW, et al. Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1996;97:749-755.
42. Bronsky EA, Dockhorn RJ, Meltzer EO, et al. Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1996;97:915-921.
43. Brooks CD, Francom SE, Peel BG, et al. Spectrum of seasonal allergic rhinitis symptom relief with topical corticoid and oral antihistamine given single or in combination. Am J Rhinol 1996;10:193-199.
44. Gèhanno P, Desgougeres JL. Fluticasone propionate aqueous nasal spray compared with oral loratadine in patients with seasonal allergic rhinitis. Allergy 1997;52:445-450.
45. Vervloet D, Charpin D, Desgougeres JL. Intranasal fluticasone once daily compared once daily cetirizine in the treatment of seasonal allergic rhinitis. Clin Drug Invest 1997;13:291-298.
46. Condemi J, Schulz R, Lim J. Triamcinolone acetonide aqueous nasal spray versus loratadine in seasonal allergic rhinitis: efficacy and quality of life. Ann Allergy Asthma Immunol 2000;84:533-538.
47. Oxman AD, Guyatt GH. Guidelines for reading literature reviews. Can Med Assoc J 1988;138:697-703.
48. Oxman AD, Cook DJ, Guyatt GH. User's guides to the medical literature: how to use an overview. JAMA 1994;272:1367-1371.
49. Sim I, Hlatky MA. Growing pains of meta-analysis. BMJ 1996;313:702-703.